SIGN-UP

EVUSHELD is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of EVUSHELD under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

STAY CONNECTED

Stay up to date on long-acting antibodies–an option for COVID-19 prevention for your immunocompromised patients.

*Indicates a required field.

IMPORTANT SAFETY INFORMATION